|
|
|
Volumn 8 Suppl 1, Issue , 2004, Pages
|
|
Targeted drugs in radiation therapy;Thérapeutiques ciblées et radiotherapie.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
IMATINIB;
MONOCLONAL ANTIBODY;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
RADIOSENSITIZING AGENT;
TRASTUZUMAB;
ANIMAL;
ARTICLE;
CELL CULTURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
HUMAN;
METABOLISM;
MOUSE;
MULTIMODALITY CANCER THERAPY;
MUTATION;
NEOPLASM;
NUDE MOUSE;
PHASE 1 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
HUMANS;
MICE;
MICE, NUDE;
MUTATION;
NEOPLASMS;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
QUINAZOLINES;
RADIATION-SENSITIZING AGENTS;
RANDOMIZED CONTROLLED TRIALS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TUMOR CELLS, CULTURED;
|
|
EID: 13744262766
PISSN: 12783218
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
